These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 27180233)

  • 1. Nail disorders in older people, and aspects of their pharmaceutical treatment.
    Murdan S
    Int J Pharm; 2016 Oct; 512(2):405-411. PubMed ID: 27180233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1st meeting on topical drug delivery to the nail.
    Murdan S
    Expert Opin Drug Deliv; 2007 Jul; 4(4):453-5. PubMed ID: 17683257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Patents on Permeation Enhancers for Drug Delivery Through Nails.
    Kreutz T; de Matos SP; Koester LS
    Recent Pat Drug Deliv Formul; 2019; 13(3):203-218. PubMed ID: 31663846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ungual and transungual drug delivery.
    Shivakumar HN; Juluri A; Desai BG; Murthy SN
    Drug Dev Ind Pharm; 2012 Aug; 38(8):901-11. PubMed ID: 22149347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into drug delivery across the nail plate barrier.
    Saner MV; Kulkarni AD; Pardeshi CV
    J Drug Target; 2014 Nov; 22(9):769-89. PubMed ID: 24964054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug delivery to the nail following topical application.
    Murdan S
    Int J Pharm; 2002 Apr; 236(1-2):1-26. PubMed ID: 11891066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of in vitro performance models in the assessment of drug delivery across the human nail for nail disorders.
    Brown M; Turner R; Wevrett SR
    Expert Opin Drug Deliv; 2018 Oct; 15(10):983-989. PubMed ID: 30173543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
    Elsayed MM
    J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A focused review on laser- and energy-assisted drug delivery for nail disorders.
    Konisky H; Klinger R; Coe L; Jaller JA; Cohen JL; Kobets K
    Lasers Med Sci; 2024 Jan; 39(1):39. PubMed ID: 38240827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iontophoretic drug delivery across the nail.
    Delgado-Charro MB
    Expert Opin Drug Deliv; 2012 Jan; 9(1):91-103. PubMed ID: 22149385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
    Bhatt V; Pillai R
    J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TranScreen-N: Method for rapid screening of trans-ungual drug delivery enhancers.
    Murthy SN; Vaka SR; Sammeta SM; Nair AB
    J Pharm Sci; 2009 Nov; 98(11):4264-71. PubMed ID: 19363796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of Hansen Solubility Parameters to predict drug-nail interactions, which can assist the design of nail medicines.
    Hossin B; Rizi K; Murdan S
    Eur J Pharm Biopharm; 2016 May; 102():32-40. PubMed ID: 26924329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: A dermatologist and nail expert group consensus.
    Rigopoulos D; Baran R; Chiheb S; Daniel CR; Di Chiacchio N; Gregoriou S; Grover C; Haneke E; Iorizzo M; Pasch M; Piraccini BM; Rich P; Richert B; Rompoti N; Rubin AI; Singal A; Starace M; Tosti A; Triantafyllopoulou I; Zaiac M
    J Am Acad Dermatol; 2019 Jul; 81(1):228-240. PubMed ID: 30731172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective treatment of severe nail psoriasis using topical calcipotriol with betamethasone dipropionate gel.
    Tan ES; Oon HH
    Indian J Dermatol Venereol Leprol; 2016; 82(3):345-7. PubMed ID: 27088952
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe 20-nail psoriasis successfully treated by low dose methotrexate.
    Lee JY
    Dermatol Online J; 2009 Nov; 15(11):8. PubMed ID: 19951644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nail Psoriasis: An Updated Review and Expert Opinion on Available Treatments, Including Biologics.
    Bardazzi F; Starace M; Bruni F; Magnano M; Piraccini BM; Alessandrini A
    Acta Derm Venereol; 2019 May; 99(6):516-523. PubMed ID: 30521057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic approach to the formulation of anti-onychomycotic nail patches.
    Rizi K; Mohammed IK; Xu K; Kinloch AJ; Charalambides MN; Murdan S
    Eur J Pharm Biopharm; 2018 Jun; 127():355-365. PubMed ID: 29530581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insight into the pathogenesis of nail psoriasis and overview of treatment strategies.
    Ventura A; Mazzeo M; Gaziano R; Galluzzo M; Bianchi L; Campione E
    Drug Des Devel Ther; 2017; 11():2527-2535. PubMed ID: 28919705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing the nail permeability of topically applied drugs.
    Murdan S
    Expert Opin Drug Deliv; 2008 Nov; 5(11):1267-82. PubMed ID: 18976136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.